IN2015DN02907A - - Google Patents

Info

Publication number
IN2015DN02907A
IN2015DN02907A IN2907DEN2015A IN2015DN02907A IN 2015DN02907 A IN2015DN02907 A IN 2015DN02907A IN 2907DEN2015 A IN2907DEN2015 A IN 2907DEN2015A IN 2015DN02907 A IN2015DN02907 A IN 2015DN02907A
Authority
IN
India
Prior art keywords
disintegrating
particle composition
tablet
acid
present
Prior art date
Application number
Other languages
English (en)
Inventor
Hiramura Takahiro
Ikura Kiyoshi
Ishikawa Sae
Okabayashi Tomohito
Hashikawa Naohiro
Morita Tetsuro
Ikeda Kimiko
Original Assignee
Daicel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daicel Corp filed Critical Daicel Corp
Publication of IN2015DN02907A publication Critical patent/IN2015DN02907A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Chemistry (AREA)
IN2907DEN2015 2012-09-20 2013-09-13 IN2015DN02907A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012206897 2012-09-20
PCT/JP2013/074823 WO2014046035A1 (ja) 2012-09-20 2013-09-13 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤

Publications (1)

Publication Number Publication Date
IN2015DN02907A true IN2015DN02907A (enExample) 2015-09-11

Family

ID=50341348

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2907DEN2015 IN2015DN02907A (enExample) 2012-09-20 2013-09-13

Country Status (8)

Country Link
US (1) US10292934B2 (enExample)
EP (1) EP2898899B1 (enExample)
JP (1) JP6230539B2 (enExample)
KR (1) KR102114487B1 (enExample)
CN (1) CN104010663B (enExample)
IN (1) IN2015DN02907A (enExample)
TW (1) TWI639446B (enExample)
WO (1) WO2014046035A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104080443B (zh) 2012-03-29 2017-12-12 株式会社大赛璐 含酸式羧甲基纤维素的崩解性颗粒组合物的制法、及该组合物和含该组合物的口腔崩解片剂
US20160136097A1 (en) * 2013-07-06 2016-05-19 Daicel Corporation Ultrafast-disintegrating tablet and method for manufacturing same
JP6302921B2 (ja) * 2013-09-27 2018-03-28 株式会社ダイセル 崩壊性粒子組成物を含む口腔内崩壊錠剤
US9974738B2 (en) 2013-09-27 2018-05-22 Daicel Corporation Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition
JP2017226600A (ja) * 2014-10-16 2017-12-28 株式会社ダイセル 超速崩壊錠剤
CA2968210A1 (en) 2014-11-24 2016-06-02 Daicel Corporation A disintegrative particulate composition comprising milled lactose or granulated lactose
JP6513702B2 (ja) * 2014-12-25 2019-05-15 株式会社ダイセル 超速崩壊錠剤及びその製造方法
TWI695722B (zh) * 2015-06-29 2020-06-11 日商大賽璐股份有限公司 固態製劑之外層用組成物及含有該外層用組成物之易服用性固態製劑
ES2607715B1 (es) 2015-10-01 2018-01-17 Solutex Na, Lcc Proceso para la preparación y estabilización de emulsiones con omega-3 mediante redes cristalinas isométricas de derivados de celulosa
JP6697874B2 (ja) * 2015-12-25 2020-05-27 日本製紙パピリア株式会社 成形材料及び成形品
WO2017126478A1 (ja) * 2016-01-18 2017-07-27 株式会社ダイセル 口腔内保持型崩壊性固形製剤、その製造方法、及び該製造方法に用いる粉体組成物
JP2019156723A (ja) * 2018-03-07 2019-09-19 大原薬品工業株式会社 圧縮成形性に優れた賦形剤を用いる、浸透膨潤型口腔内崩壊錠
JP7036856B2 (ja) * 2019-03-28 2022-03-15 日本ケミファ株式会社 口腔内崩壊錠
JP6744517B1 (ja) * 2019-11-07 2020-08-19 旭化成株式会社 セルロース組成物、錠剤及び口腔内崩壊錠
WO2021099531A1 (en) 2019-11-22 2021-05-27 Biohorm, S.L. Zonisamide orodispersible tablets

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851453A (en) 1954-08-09 1958-09-09 Smith Kline French Lab Cellulose derivative product, compositions comprising the same and their preparation
JPH10182436A (ja) 1996-10-31 1998-07-07 Takeda Chem Ind Ltd 固形医薬製剤
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP2000290172A (ja) * 1999-04-09 2000-10-17 Earth Chem Corp Ltd 発泡タブレット
JP4284017B2 (ja) 2000-10-06 2009-06-24 武田薬品工業株式会社 固形製剤
US7510728B2 (en) * 2000-10-06 2009-03-31 Takeda Pharmaceutical Company Limited Solid preparations
JP4551627B2 (ja) 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
US20080274178A1 (en) 2005-08-10 2008-11-06 Shionogi & Co., Ltd. Orally Disintegrating Tablet
JP5123517B2 (ja) 2005-11-14 2013-01-23 帝人ファーマ株式会社 アンブロキソール口腔内速崩性錠剤
JP5766899B2 (ja) 2007-04-11 2015-08-19 ニプロ株式会社 口腔内崩壊剤及びその製造方法
JP2008285434A (ja) 2007-05-16 2008-11-27 Taisho Pharm Ind Ltd 口腔内速崩壊錠
EP2164462B1 (de) 2007-06-06 2017-05-31 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
US20110053942A1 (en) * 2008-02-13 2011-03-03 Dainippon Sumitomo Pharma Co., Ltd. Orally disintegrating tablets
JP5674666B2 (ja) 2009-08-11 2015-02-25 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
CN102548542B (zh) * 2009-08-11 2013-11-20 大日本住友制药株式会社 含有两种以上粒子的口腔速崩片
US20110150989A1 (en) 2009-12-22 2011-06-23 Mallinkckrodt Inc. Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
JP6073543B2 (ja) 2010-07-08 2017-02-01 沢井製薬株式会社 ロラタジン含有口腔内崩壊錠の製造方法
JP6245677B2 (ja) * 2012-01-20 2017-12-13 ニプロ株式会社 口腔内崩壊錠
CN104080443B (zh) 2012-03-29 2017-12-12 株式会社大赛璐 含酸式羧甲基纤维素的崩解性颗粒组合物的制法、及该组合物和含该组合物的口腔崩解片剂

Also Published As

Publication number Publication date
TW201417843A (zh) 2014-05-16
JPWO2014046035A1 (ja) 2016-08-18
EP2898899B1 (en) 2019-09-11
US10292934B2 (en) 2019-05-21
WO2014046035A1 (ja) 2014-03-27
KR20150056636A (ko) 2015-05-26
US20150238424A1 (en) 2015-08-27
KR102114487B1 (ko) 2020-05-22
EP2898899A4 (en) 2016-03-16
TWI639446B (zh) 2018-11-01
CN104010663A (zh) 2014-08-27
JP6230539B2 (ja) 2017-11-15
EP2898899A1 (en) 2015-07-29
CN104010663B (zh) 2021-02-19

Similar Documents

Publication Publication Date Title
CA2871471C (en) Dna-pk inhibitors
EA033343B1 (ru) Соединения, ингибирующие rip2-киназу, фармацевтическая композиция на их основе и их применение для лечения заболеваний, опосредуемых rip2-киназой
PH12015501385A1 (en) Autotaxin inhibitors
MY189427A (en) Pyrazolyl quinoxaline kinase inhibitors
IN2015DN01156A (enExample)
GEP20156347B (en) Benzodioxane inhibitors of leukotriene production
EP4036240A3 (en) Transduction buffer
SG171542A1 (en) Pharmaceutical composition comprising a strontium salt, vitamin d and a cyclodextrin
TN2012000534A1 (en) Pyrazole compounds as sigma receptor inhibitors
IN2013MU03583A (enExample)
MX2021011906A (es) Composiciones de liberacion retardada de linaclotida.
WO2015019198A3 (en) High potency pancreatin pharmaceutical compositions
WO2011048563A3 (en) Orally disintegrating tablets of betahistine
WO2011104652A3 (en) Veterinary compositions
MY195343A (en) A Novel Phtalazinone Derivatives and Manufacturing Process Thereof
PH12012502153A1 (en) Enteric tablet
HK1222325A1 (zh) 高效的胰酶藥物組合物
MX2012001691A (es) Composiciones de linaclotida que se desintegran oralmente.
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
CA2890042C (en) 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives
IN2014DN03010A (enExample)
MX2010008707A (es) Composiciones farmaceuticas de entacapona comicronizada con alcoholes de azucar.
WO2010086617A3 (en) Phosphoantigens for the treatment of burkholderia infections
WO2014122671A3 (en) Solid oral compositions of saxagliptin
IN2013CH04314A (enExample)